Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

被引：0
|
作者：
Haricharan, Svasti [1 ]
Punturi, Nindo [1 ]
Seker, Sinem [1 ]
Devarakonda, Vaishnavi [2 ]
Kalra, Rashi [2 ]
Chen, Ching-Hui [2 ]
Mazumder, Aloran [1 ]
Li, Shungqiang [3 ]
Primeau, Tina [3 ]
Ellis, Matthew [2 ]
Kavuri, Shyam [2 ]
机构：
[1] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Washington Univ, St Louis, MO 63110 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD8-05
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Is HER2 expression related to CDKi efficacy in HER2-negative luminal metastatic breast cancer?
    Rodriguez Garces, Maria Yeray
    Fernandez Madrigal, Laura
    Morales Pancorbo, David
    Bayo, Juan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [12] Protein-protein interaction of HER2 predicts the prognosis of hormone receptor-positive HER2-negative breast cancer
    Choi, Hee Jun
    Lee, Hong Won
    Kim, Sangmin
    Yoon, Tae-Young
    Kim, Hyunwoo
    Lee, Seul
    Nam, Seok Jin
    Kim, Seok Won
    Cho, Sooyoun
    Park, Yeon Hee
    Lee, Jeong Eon
    CANCER RESEARCH, 2020, 80 (04)
  • [13] HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
    Luo, Hai
    Cui, Lingzhi
    Shen, Kexin
    Li, Ruiqi
    Wang, Zeming
    Xie, Zhongshi
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3443 - 3454
  • [14] Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative,-Low, and-Positive Metastatic Breast Cancer
    Eisses, Bertha
    van Geel, Jasper J. L.
    Brouwers, Adrienne H.
    Bensch, Frederike
    Elias, Sjoerd G.
    Kuip, Evelien J. M.
    Jager, Agnes
    van der Vegt, Bert
    Lub-de Hooge, Marjolijn N.
    Emmering, Jasper
    Arens, Anne I. J.
    Zwezerijnen, Gerben J. C.
    Vugts, Danielle J.
    van Oordyt, C. Willemien Menke-van der Houven
    de Vries, Elisabeth G. E.
    Schroder, Carolina P.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (10) : 1540 - 1547
  • [15] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Yue, Meng
    Wu, Si
    Liu, Chang
    Cai, Lijing
    Wang, Xinran
    Jia, Ying
    Han, Dandan
    Liu, Yueping
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 373 - 381
  • [16] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    CANCER RESEARCH, 2021, 81 (04)
  • [17] The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
    Coriano, Matilde
    Tommasi, Chiara
    Dinh, Anh Thi Lan
    Needham, Jazmine
    Aziz, Hala
    Joharatnam-Hogan, Nalinie
    Cunningham, Niamh
    Waterhouse, Jasmin
    Sun, Mingze
    Turkes, Fiona
    Pellegrino, Benedetta
    Mcgrath, Sophie
    Okines, Alicia
    Parton, Marina
    Turner, Nicholas
    Johnston, Stephen
    Musolino, Antonino
    Ring, Alistair
    Battisti, Nicolo Matteo Luca
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (03) : 603 - 614
  • [18] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Meng Yue
    Si Wu
    Chang Liu
    Lijing Cai
    Xinran Wang
    Ying Jia
    Dandan Han
    Yueping Liu
    Breast Cancer Research and Treatment, 2024, 203 : 373 - 381
  • [19] Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations
    Tian, Hao
    Qu, Man
    Zhang, Guozhi
    Yuan, Long
    Shi, Qiyun
    Wang, Yinhuan
    Yang, Ying
    Zhang, Yi
    Qi, Xiaowei
    ONCOLOGIST, 2023, 28 (07): : E534 - E541
  • [20] HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers
    Wang, Tonghui
    Xu, Ye
    Sheng, Shuyan
    Yuan, Hua
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    CANCER SCIENCE, 2017, 108 (04): : 671 - 677
12345